Raymond James Financial Services Advisors, Inc. Harmony Biosciences Holdings, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 30,571 shares of HRMY stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,571
Previous 46,125
33.72%
Holding current value
$1.27 Million
Previous $1.39 Million
12.22%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HRMY
# of Institutions
226Shares Held
45.1MCall Options Held
48.2KPut Options Held
61.5K-
Valor Management LLC Chicago, IL11.2MShares$465 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$242 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.52MShares$146 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$108 Million11.62% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.51MShares$104 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.45B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...